This page shows the latest MaxCyte news and features for those working in and with pharma, biotech and healthcare.
MaxCyte has two sides to its business, developing its own therapies on one hand and on the other licensing its flow electroporation platform for use by other companies. ... MaxCyte’s approach could mean that its therapies are quicker and easier to
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Another example is Maxcyte, a global cell- based therapies and life sciences company that is developing its CARMA process, where a patient’s peripheral blood mononuclear cells (PBMCs) are removed and
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...